Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma
Journal of Neurological Surgery Part B: Skull Base · 01.06.2023 · 84 (03) · 232-239
DOI: 10.1055/a-1780-4157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.06.2023. Verfasst von Rijul S Kshirsagar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United …. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
Although adjuvant radiotherapy may be indicated in patients with sinonasal squamous cell carcinoma (SNSCC) following primary surgery, some patients choose to forgo recommended postoperative radiation therapy (PORT). This study aimed to elucidate factors associated with patient refusal of recommended PORT in SNSCC and examine overall survival.
Methods
Retrospective analysis of patients with SNSCC treated with primary surgery from the National Cancer Database diagnosed between 2004 and 2016. A multivariable logistic regression model was created to determine the association between clinical or demographic covariates and likelihood of PORT refusal. Unadjusted Kaplan–Meier estimates, log-rank tests, and a multivariable Cox proportional hazard model were used to assess overall survival.
Results
A total of 2,231 patients were included in the final analysis, of which 1,456 (65.3%) were males and 73 (3.3%) refused recommended PORT. Patients older than 74 years old were more likely to refuse PORT than those younger than 54 (odds ratio [OR] 3.43, 95% confidence interval [CI]: 1.84–6.62). Median survival among the entire cohort, those who received recommended PORT, and those who refused PORT was 83.0 months (95% CI: 74.6–97.1), 83.0 months (95% CI: 74.9–98.2), and 63.6 months (95% CI: 37.3–101.4), respectively. Refusal of PORT was not associated with overall survival (hazard ratio: 0.99, 95% CI: 0.69–1.42).
Conclusions
PORT refusal in patients with SNSCC is rare and was found to be associated with several patient factors. The decision to forgo PORT is not independently associated with overall survival in this cohort. Further study is required to determine the clinical implications of these findings as the treatment decisions are complex.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
ORCID-Profile: Rijul S Kshirsagar
Zitieren
APA
Kshirsagar, R. S., Eide, J. G., Prasad, A., Carey, R. M., Rajasekaran, K., Brant, J. A., Newman, J. G., Palmer, J. N., & Adappa, N. D. (2023). Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma. Journal of Neurological Surgery Part B: Skull Base, 84(03), 232-239. https://doi.org/10.1055/a-1780-4157
Vancouver
Kshirsagar RS, Eide JG, Prasad A, Carey RM, Rajasekaran K, Brant JA, et al. Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma. Journal of Neurological Surgery Part B: Skull Base. 2023;84(03):232-239. doi:10.1055/a-1780-4157
BibTeX
@article{Kshirsagar2023,
author = {Kshirsagar, Rijul S and Eide, Jacob G and Prasad, Aman and Carey, Ryan M and Rajasekaran, Karthik and Brant, Jason A and Newman, Jason G and Palmer, James N and Adappa, Nithin D},
title = {Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2023},
volume = {84},
number = {03},
pages = {232--239},
doi = {10.1055/a-1780-4157}
}
EUVIMED